BioHarvest Sciences Inc.
BHST
$6.71
-$0.09-1.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 52.86% | -2.78% | -111.33% | -57.08% | -86.58% |
| Total Depreciation and Amortization | 71.56% | 48.93% | 37.99% | 25.09% | 9.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -92.20% | 126.11% | 751.09% | 105,225.00% | 315,066.67% |
| Change in Net Operating Assets | 86.09% | -173.51% | -167.09% | 7,275.00% | -149.71% |
| Cash from Operations | 22.64% | 21.57% | 9.25% | 31.57% | -0.62% |
| Capital Expenditure | -149.77% | -92.33% | -89.00% | -107.08% | -6.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -164.02% | -105.36% | -101.80% | -124.59% | -6.37% |
| Total Debt Issued | -48.06% | -75.48% | -19.04% | -21.56% | 53.35% |
| Total Debt Repaid | -232.68% | -249.45% | -40.62% | -25.14% | -20.94% |
| Issuance of Common Stock | 1,035.82% | 1,075.68% | 1,072.77% | 317.81% | -43.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -21.87% | -49.99% | 29.13% | 10.95% | 47.19% |
| Foreign Exchange rate Adjustments | -144.87% | -157.63% | 723.08% | 808.33% | 277.27% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -101.12% | -181.93% | 269.57% | 461.20% | 424.64% |